GeneTex
United States (US)

TARC recombinant protein

Cat No. GTX65245

Application ELISA, Functional Assay, Apuri, Blocking
Reactivity Human
Species Human
APPLICATION

Application Note

Protein's bioactivity determined by its ability to chemoattract human T-Lymphocytes using a concentration range of 1.0-10.0 ng/ml.

Calculated MW

8.0 kDa. ( Note )
PROPERTIES

Form

Lyophilized powder

Buffer

20 mM PBS & 150 mM NaCl pH7.4.

Storage

Reconstitute in water to a concentration of 0.1-1.0 mg/ml. This solution can then be diluted into other aqueous buffers. Reconstitute in ddH2O. Store at -20ºC. Product is stable for at least 12 months.

Antigen Species

Human

Expression System

E. coli

Purification


Purity was assessed by SDS-PAGE (≥97%) and by HPLC (≥97%).

Note

For laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
TARGET

Synonyms

CC motif chemokine17, Smallinducible cytokine A17, Thymus and activationregula, SCYA17, CCL17, Thymus and activationregulated chemokine, Thymus and activation-regulated chemokine, CC chemokine TARC, A-152E5, ABCD-2, Small-inducible cytokine A17, ABCD2, CC motif chemokine 17, CCL-17, C-C motif chemokine 17, A152E5, A-152E5.3, MGC138271, MGC138273, TARC, ABCD 2, CCL 17, A 152E5, A 152E5.3, C C motif chemokine 17, Small inducible cytokine A17, A152E5.3

Background

Human TARC is a recently discovered protein belonging to the beta-chemokine (C-C) family of cytokines. It has been shown that TARC is chemotactic towards T-cells but ineffective on monocytes. The recombinant human TARC is an 8.0 kDa protein containing 71 amino acid residues.
Package List Price ($)
$ 259